Northrop Grumman reported a record backlog and described demand conditions as the strongest in over two decades during a presentation at Morgan Stanley's 14th Annual Laguna Conference on Thursday, September 17, 2026.
CEO Kathy Warden said the company has "a record backlog once again," noting that the current demand environment is "one of the most robust" she has seen in her 20-plus years in the aerospace and defense industry. Sentinel intercontinental ballistic missile program orders reached $7.6 billion in the most recent quarter, while the national security space segment — representing roughly 15% of total revenue — carried a backlog above $16 billion and was tracking toward more than $7 billion in annual revenue, growing in the high single digits.
Production of the B-21 Raider bomber accelerated earlier in 2024, with first tests for both the B-21 and Sentinel programs planned for 2027. Sentinel is targeting Milestone B approval by year-end. The U.S. Air Force is expected to share analysis with Congress by year-end on whether to expand the B-21 fleet beyond the current 100-aircraft plan.
Warden emphasized that the Air Force views the B-21 as a "multifunctional aircraft" capable of missions beyond its nuclear deterrent role within the strategic triad.
On munitions, Northrop disclosed 10 multi-year agreements across approximately eight weapons systems, totaling roughly $10 billion over seven years. The company pre-invested in infrastructure following its 2019 acquisition of Orbital ATK, building two additional plants and bringing two others near completion. Warden said this positioned Northrop for potential volume multipliers of 2x to 5x on products such as PAC-3 solid rocket motors.
International sales are targeted to double to $10 billion by 2031. Capital expenditures are projected to remain elevated at around 4.5% of sales through 2027 and 2028. The company's "Golden Dome" missile defense architecture aims for initial operating capability in 2028.
Financially, Northrop confirmed 2026 free cash flow guidance of $3.1 billion to $3.5 billion. The aeronautics segment posted a 10.3% margin in the second quarter, with full-year guidance in the mid-to-high 9% range. Return on equity over the trailing twelve months stood at 27%, and the company's Piotroski Score was 9.
Warden addressed federal budget dynamics, stating that Northrop's programs are "largely supported in the base budget and fully funded there," with reconciliation money viewed as "largely upside to the outlook." She acknowledged that extended continuing resolutions cost the government more and are not ideal for national security, but added that the company has funding visibility into early 2025 despite a CR extension expected into early December.
Northrop shares closed at $524.02 on Wednesday, down 1.27% from the prior close of $530.78. The stock's 52-week range is $479.02 to $774.
